Use of an Alzheimer’s disease polygenic risk score to identify mild cognitive impairment in adults in their 50s-Reference-Cited by-同舟云学术

Use of an Alzheimer’s disease polygenic risk score to identify mild cognitive impairment in adults in their 50s

Published:2018-02-27 Issue:3 Volume:24 Page:421-430
ISSN:1359-4184
Container-title:Molecular Psychiatry
language:en
Short-container-title:Mol Psychiatry

Author:

Logue Mark W.,Panizzon Matthew S.,Elman Jeremy A.^ORCID,Gillespie Nathan A.,Hatton Sean N.,Gustavson Daniel E.,Andreassen Ole A.^ORCID,Dale Anders M.,Franz Carol E.,Lyons Michael J.,Neale Michael C.,Reynolds Chandra A.,Tu Xin,Kremen William S.

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology

Link

http://www.nature.com/articles/s41380-018-0030-8.pdf

Reference58 articles.

1. Golde TE, Schneider LS, Koo EH. Anti-abeta therapeutics in Alzheimer’s disease: the need for a paradigm shift. Neuron. 2011;69:203–13.

2. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:280–92.

3. Sperling RA, Jack CR Jr, Aisen PS. Testing the right target and right drug at the right stage. Sci Transl Med. 2011;3:111cm133.

4. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dement. 2011;7:270–9.

5. Petersen RC, Morris JC. Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol. 2005;62:1160–3.

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of genetic predisposition to late-onset neurodegenerative diseases on early life outcomes and brain structure;Translational Psychiatry;2024-04-11

2. Disentangling Accelerated Cognitive Decline from the Normal Aging Process and Unraveling Its Genetic Components: A Neuroimaging-Based Deep Learning Approach;Journal of Alzheimer's Disease;2024-02-13

3. Accelerated brain change in healthy adults is associated with genetic risk for Alzheimer’s disease and uncovers adult lifespan memory decline;2023-10-12

4. Pathway-Specific Polygenic Risk Scores Correlate with Clinical Status and Alzheimer’s Disease-Related Biomarkers;Journal of Alzheimer's Disease;2023-09-26

5. Disentangling accelerated cognitive decline from the normal aging process and unraveling its genetic components: A neuroimaging-based deep learning approach;2023-09-08